CDKL3 Antikörper (AA 51-150) (Cy5)
Kurzübersicht für CDKL3 Antikörper (AA 51-150) (Cy5) (ABIN714150)
Target
Alle CDKL3 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 51-150
-
Homologie
- Human,Mouse,Rat,Dog,Cow,Sheep,Horse,Rabbit
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human CDKL3/NKIAMRE
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- CDKL3 (Cyclin-Dependent Kinase-Like 3 (CDKL3))
-
Andere Bezeichnung
- CDKL3
-
Hintergrund
-
Synonyms: CDKL3 protein, Cyclin dependent kinase like 3, CDKL3_HUMAN.
Background: A novel cyclin-dependent kinase-related molecule, NKIAMRE, has been identified that is thought to be a tumor suppressor locus. The NKIAMRE gene is located on chromosome 5q, a region that is often deleted in human acute leukemia and human myeloid dysplastic disorders.
-
Gen-ID
- 51265
-
Pathways
- Zellzyklus
Target
-